Survival RateDisease-Free SurvivalPrognosisNeoplasm StagingSurvival AnalysisTreatment OutcomeRetrospective StudiesCombined Modality TherapyNeoplasm Recurrence, LocalKaplan-Meier EstimateCell SurvivalBreast NeoplasmsFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantTumor Markers, BiologicalLymphatic MetastasisRadiotherapy, AdjuvantProportional Hazards ModelsTime FactorsImmunohistochemistrySurvivalRadiotherapy DosageFluorouracilCarcinoma, Squamous CellGraft SurvivalMultivariate AnalysisLiver NeoplasmsNeoplasm InvasivenessCyclophosphamideColorectal NeoplasmsAdenocarcinomaRecurrenceCarcinomaProspective StudiesCarcinoma, Ductal, BreastImmunoenzyme TechniquesPredictive Value of TestsReceptors, EstrogenRisk FactorsReceptor, erbB-2Lung NeoplasmsCisplatinNeoplasm MetastasisGene Expression Regulation, NeoplasticAntineoplastic AgentsVincristineDoxorubicinCyclooxygenase 2 InhibitorsNeoplasm GradingRemission InductionCohort StudiesCarcinoma, Non-Small-Cell LungActuarial AnalysisNeoadjuvant TherapyDrug Administration ScheduleBone NeoplasmsEtoposideAge FactorsCarcinoma, HepatocellularChemoradiotherapySalvage TherapyOvarian NeoplasmsLymph Node ExcisionSarcomaRadiotherapyPrednisoneMethotrexateHead and Neck NeoplasmsStomach NeoplasmsPancreatic NeoplasmsApoptosisBrain NeoplasmsRisk AssessmentLymphoma, Non-HodgkinCarboplatinBrachytherapyTransplantation, HomologousReceptors, ProgesteroneHepatectomyHodgkin DiseaseCell Line, TumorLymph NodesRectal NeoplasmsOsteosarcomaPaclitaxelTransplantation, AutologousRegistriesHematopoietic Stem Cell TransplantationNeoplasm ProteinsNeoplasms, Germ Cell and EmbryonalDose FractionationPostoperative ComplicationsNeoplasm, ResidualDeoxycytidineAntibodies, MonoclonalMelanomaFree RadicalsCell ProliferationReverse Transcriptase Polymerase Chain Reaction